The
power
of our
people
and
platform
The
power
of our
people
and
platform
Focus
Excellence
Results
About Stifel Institutional
Stifel’s mission is to offer expert guidance and resources to help you achieve your goals.
Stifel is a global full-service investment bank offering brokerage, trading, research, underwriting, and advisory services. We build long-term client relationships and deliver tailored solutions across public and private markets through the depth of our platform and expertise.
See how Stifel is shaping the market through its latest developments, expert insights, and client partnerships
Learn MoreCapabilities
Notable Transactions
$ 86,250,000,000
Co-Manager
IPO
Aerospace, Defense & Government Services
Jun 2026
$ 1,512,000,000
Joint Bookrunning Manager
Initial Public Offering
Industrial Technology, Engineering & Construction, and Infrastructure
Feb 2026
$175,000,000
Joint Bookrunner
Follow-on Offering
Biopharma
Mar 2025
$202,000,000
Joint Bookrunning Manager
Initial Public Offering
Medtech
Mar 2025
Advisor to Seller
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Mar 2025
Lender
Senior Secured Credit Facilities
Engineering & Construction, and Infrastructure
Mar 2025
€1,320,000,000
Joint Bookrunner/Joint Lead Financial Advisor
Refinancing
Gaming & Leisure
Feb 2025
A$80,000,000
Joint Lead Arranger & Joint Bookrunner
Follow-on Offering
Energy & Natural Resources
Feb 2025
C$131,000,000
Advisor to Seller
Mergers & Acquisitions
Industrial & Environmental Services
Feb 2025
$219,200,000
Joint Bookrunner
Initial Public Offering
Biopharma
Feb 2025
$384,000,000
Joint Bookrunner
Initial Public Offering
Building Products
Feb 2025
$150,000,000
Joint Bookrunner
Follow-on Offering
Biopharma
Feb 2025
Advisor to Buyer
Mergers & Acquisitions
Healthcare
Feb 2025
$230,000,000
Left Bookrunner
Follow-on Offering
Energy & Natural Resources
Feb 2025
$75,000,000
Joint Bookrunner
Follow-on Offering
Biopharma
Jan 2025
Advisor to Seller
Mergers & Acquisitions
Software
Dec 2024
Advisor to Pieris
Mergers & Acquisitions
HealthTech
Dec 2024
$50,000,000
Joint Bookrunner
Registered Direct
Biopharma
Dec 2024
$257,600,000
Joint Bookrunner
Follow-on Offering
Biopharma
Dec 2024
$350,000,000
Joint Bookrunner
Senior Secured Notes
Paper & Forest Products, Diversified Industries
Dec 2024
$1,075,000,000
Joint Lead Arranger
Senior Secured Credit Facilities
Packaging, Diversified Industries
Dec 2024
Advisor to Seller
Mergers & Acquisitions
HealthTech
Dec 2024
$624,800,000
Joint Bookrunner
Initial Public Offering
Software
Dec 2024
Advisor to Seller
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Dec 2024
$402,500,000
Joint Bookrunner
Follow-on Offering
Biopharma
Dec 2024
$115,000,000
Joint Bookrunner
Confidentially Marketed Follow-on Offering
Aerospace, Defense & Government Services
Dec 2024
Advisor to Buyer
Mergers & Acquisitions
Food & Beverage
Dec 2024
$390,000,000
Advisor to Seller
Mergers & Acquisitions
Transportation & Logistics
Dec 2024
Advisor to Buyer
Mergers & Acquisitions
Business Services
Dec 2024
Advisor to Buyer
Mergers & Acquisitions
Tech-Enabled Services
Nov 2024
$196,956,533
Joint Bookrunner
Follow-on Offering
Energy & Natural Resources
Nov 2024
Advisor to Seller
Mergers & Acquisitions
Software
Nov 2024
Advisor to Seller
Mergers & Acquisitions
Restaurants
Nov 2024
$152,500,000
Joint Bookrunner
Follow-on Offering
Aerospace, Defense & Government Services
Nov 2024
$60,000,000
Joint Bookrunner & Joint Placement Agent
Registered Direct & PIPE
Biopharma
Nov 2024
Advisor to Buyers
Mergers & Acquisitions
Food & Beverage
Nov 2024
$610,000,000
Joint Lead Arranger
Senior Secured Credit Facilities
Food & Beverage
Nov 2024
$900,000,000
Joint Bookrunner
Senior Secured Notes
Food & Beverage
Nov 2024
Advisor to Buyer
Mergers & Acquisitions
Biopharma
Oct 2024
$2,200,000,000
Advisor to Buyer
Mergers & Acquisitions
Tech-Enabled Services
Oct 2024
$2,435,000,000
Joint Lead Arranger
Senior Secured Credit Facilities
Tech-Enabled Services
Oct 2024
$172,499,859
Joint Bookrunner
Follow-on Offering
Aerospace, Defense & Government Services
Oct 2024
Sole Financial Advisor
Mergers & Acquisitions
Healthcare Services
Oct 2024
Advisor to Seller
Mergers & Acquisitions
Transportation & Logistics
Sep 2024
$94,500,000
Joint Bookrunner
Follow-on Offering
Real Estate
Sep 2024
Advisor to Seller
Mergers & Acquisitions
Software
Sep 2024
$517,500,000
Joint Bookrunner
Follow-on Offering
Industrial & Environmental Services
Sep 2024
$150,000,000
Joint Bookrunner
Senior Notes
Energy & Natural Resources
Sep 2024
$575,000,000
Joint Bookrunner
Follow-on Offering
Biopharma
Sep 2024
$362,250,000
Joint Bookrunner
Initial Public Offering
Biopharma
Sep 2024
$187,680,000
Joint Bookrunner
Initial Public Offering
Biopharma
Sep 2024
$258,750,000
Joint Bookrunning Manager
Follow-on Offering
Biopharma
Sep 2024
$200,536,320
Joint Placement Agent
PIPE
Biopharma
Sep 2024
$200,000,000
Joint Bookrunner
Follow-on Offering
Biopharma
Sep 2024
$152,173,925
Joint Bookrunner
Follow-on Offering
Energy & Natural Resources
Sep 2024
$137,000,000
Follow-on Offering
Energy & Natural Resources
Sep 2024
$220,000,000
Sole Bookrunner
Initial Public Offering
Business Services
Sep 2024
$96,000,000
Joint Bookrunner
Follow-on Offering
Aerospace, Defense & Government Services
Sep 2024
$258,750,000
Joint Bookrunner
Confidentially Marketed Follow-on Offering
Biopharma
Aug 2024
$130,000,000
Joint Bookrunner
Registered Direct
Biopharma
Aug 2024
Advisor to Seller
Mergers & Acquisitions
Engineering & Construction, and Infrastructure
Aug 2024
Advisor to Seller
Mergers & Acquisitions
Healthcare, Biopharma
Aug 2024
C$180,000,000
Left Bookrunner
Private Placement
Metals & Mining
Aug 2024
Sole Placement Agent
Senior Secured Credit Facilities
Consumer Products
Aug 2024
$100,000,000
Lead Financial Advisor
Convertible Notes & Senior Secured Term Loan
Medtech
Aug 2024
$33,900,000
Sole Bookrunner
Follow-on Offering
Biopharma
Aug 2024
$85,000,000
Project Gear
Advisor to Sponsor
Private Capital Advisory
2024
Advisor to Seller
Mergers & Acquisition
Capital Goods
Aug 2024
$128,000,000
Financial Advisor
SPAC Merger
Medtech
Jul 2024
Advisor to Seller
Mergers & Acquisitions
Healthcare
Jul 2024
$231,000,000
Joint Bookrunner
Follow-on Offering
Energy & Natural Resources
Jul 2024
$310,000,000
Advisor to Seller
Mergers & Acquisitions
Medtech, Healthcare
Jul 2024
$92,500,000
Advisor to Buyer
Mergers & Acquisitions
Digital Assets
Jul 2024
$395,000,000
Advisor to Seller
Mergers & Acquisitions
Industrial Technology
Jul 2024
Advisor to Seller
Mergers & Acquisitions
Biopharma
Jul 2024
Dollar volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp.
Awards & Recognitions
National and international recognition of Stifel’s successful approach.
Top Ranked
U.S. Mid-Market Equity House of the Year
International Financing Review, 2023
Leader
In Volume of Senior Managed Negotiated Municipal Bond Issues
Thomson Reuters
Largest
Provider of Global Small-Cap Equity Research Coverage
Company data as of 12/31/24
Insights & Perspectives
Stay up to date with the trends shaping markets, economies, and industries at home and across the world. Here’s Stifel in the press.
Media & Press
Back to top
